PVSRIPO replicates in CD155+ tumor and APCs, leading to direct oncolysis and innate immune activation through MDA-mediated type I interferon signaling, which enhances dendritic cell maturation and CD8+ T cell priming [163,164]. Here, CD8A is linked to neoplasm.